Abstract
There have been recent significant improvements in treatment options for patients with advanced renal cell carcinoma. This article presents UK consensus guidelines on the use of systemic therapies for this poor prognosis disease.
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Antineoplastic Agents / therapeutic use*
-
Carcinoma, Renal Cell / drug therapy*
-
Clinical Trials as Topic
-
Evidence-Based Medicine
-
Humans
-
Kidney Neoplasms / drug therapy*
-
Practice Guidelines as Topic*
-
Prognosis
-
United Kingdom